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A Case of Congenital Central Hypoventilation Syndrome with 
PHOX2B Gene Mutation in a Korean Neonate
Congenital central hypoventilation syndrome (CCHS) is a life-threatening disorder with 
apnea and cyanosis during sleep requiring immediate endotracheal intubation during the 
first day of life. The PHOX2B gene has been identified as the major gene involved in CCHS. 
This is the first report of a Korean neonate with CCHS confirmed to have a PHOX2B 
mutation with expanded alleles containing 20 polyalanine repeats that is a relatively small 
number compared to previous cases. The patient required intermittent ventilator support 
during sleep only and did not suffer from any other disorders of the autonomic nerve 
system. He consistently needs ventilator support during sleep and remains alive. Analysis of 
PHOX2B gene is useful for diagnosis and appropriate therapeutic intervention of CCHS 
patients.
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CASE REPORT
Pediatrics
INTRODUCTION
Congenital central hypoventilation syndrome (CCHS) is a rare 
autosomal dominant disorder of the autonomic nervous system 
(ANS) characterized by an abnormal autonomic ventilatory re-
sponse to progressive hypercapnia and sustained hypoxemia. 
Most patients present with hypoventilation or apnea during the 
neonatal period, typically while asleep and/or awake without 
any other associated diseases such as cardiac, pulmonary, neu-
romuscular or brain stem abnormalities (1, 2). A rare associa-
tion with Hirschsprung disease (Haddad syndrome) was first 
described in 1978; five cases of Haddad syndrome have been 
reported in Korea (3-7). It is because of the association with 
aganglionosis of the bowel that a number of candidate genes 
have been considered.
  A common pathogenesis involving neural crest-derived cell 
lineages has been suggested (8). Studies of genes pertinent to 
the early embryologic development of the ANS include the mam-
malian achaetescute homolog-1 (MASH1), bone morphogenic 
protein-2 (BMP2), engrailed-1 (EN1), TLX3, endothelin con-
verting enzyme-1 (ECE1), endothelin-1 (EDN1), PHOX2A, and 
PHOX2B among 67 probands with CCHS. No disease-defining 
mutations were identified in MASH1, BMP2, EN1, TLX3, ECE1, 
EDN1, or PHOX2A. However, 97% of patients with CCHS have 
been found to be heterozygous for the exon 3 polyalanine ex-
pansion mutation identified previously in PHOX2B (9). PHOX2B 
has been mapped to chromosome 4p12 and consists of 3 exons. 
It encodes a highly conserved paired-like homeo box transcrip-
tion factor of 314 amino acids linked to the RET-GDNF signal-
ing pathway. The DNA binding homeo domain is encoded by 
exon 2, whereas exon 3 encodes two short and stable polyala-
nine tracts of 9 and 20 residues (2). Expression studies performed 
in mice and humans have shown that this is a master regulatory 
gene, crucial for the normal development of the peripheral and 
central ANS (10-12). We herein report a case of CCHS in a Korean 
patient that was confirmed during the neonatal period by the 
identification of PHOX2B mutations.
CASE REPORT
Clinical history
A 3,070 g male at 41 weeks gestation age was born in our hospi-
tal via cesarean section because of cephalopelvic disproportion 
on July 26, 2007. His mother was healthy during her pregnancy 
(gravida 1, para 0). The boy was well at birth, with Apgar scores 
of 7 and 9 at 1 and 5 min, respectively. He repeatedly had apnea 
with cyanosis and desaturation, noticed from the 15 hr after 
birth, and improved by awakening. He sometimes developed 
seizures when the PaCO2 accumulated, which needed support-
ive care with mechanical ventilation. No abnormalities were 
noted on the chest radiograph, EEG (Fig. 1), MRI of the brain, 
echocardiography and screening blood tests for metabolic dis-
ease. Symptoms of respiratory failure with slow and irregular 
respiratory effort, cyanosis and seizures due to hypercapnia  
appeared during sleep but not during wakefulness (Fig. 2). The 
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for the gene study were obtained from the patient and his moth-
er at the age of 33 days with consented document of the family.
  The infant could not weaned from mechanical ventilation 
due to sleep apnea. He had a tracheostomy and was discharged 
with a home mechanical ventilation. At the age of 27 months, 
he is healthy except still ventilator-dependent during sleep. The 
patient achieved normal growth and development. 
DNA preparation
Blood (4 mL) was collected into an EDTA tube from the patient 
and his mother. Genomic DNA was obtained using a Puregene 
reagent kit (Gentra, Minneapolis, MN, USA) according to the 
manufacturer’s instructions.
Genotyping of PHOX2B polyalanine repeat sequence
The PHOX2B exon 3 region coding for the polyalanine repeat 
was amplified with primer pair 5’-CCAGGTCCCAATCCCAAC- 
3’ (forward) and 5’-GAGCCCAGCCTTGTCCAG-3’ (reverse) (Fig. 
3). The PCR reactions were carried out using 0.25 U AmpliTaq 
Gold polymerase (Applied Biosystems, Foster City, CA, USA) in 
a total volume of 25 μL, containing 50 ng genomic DNA, 0.3 μM 
primers, 2.5 mM MgCl2, and 0.2 mM dNTPs. The amplification 
was performed with an initial denaturation at 95°C for 10 min 
followed by 35 cycles of denaturation at 94°C for 30 sec, anneal-
ing at 57°C for 30 sec, and extension at 72°C for 30 sec. Final ex-
tension was at 72°C for 10 min. After electrophoresis of the PCR 
products on a 4% denaturing polyacrylamide gel, the allele re-
peat number was determined by comparison of bands to known 
size standards (232 bp for normal 20 repeat allele) (9). 
Sequence analysis of PHOX2B exons 2 and 3 region
PHOX2B exons 2 and 3 were amplified with primer pairs noted 
in Table 1. The amplification of exon 2 was carried out using 1.25 
U AmpliTaq Gold polymerase (Applied Biosystems) in a total 
volume of 25 μL, containing 50 ng of genomic DNA, 0.5 μM of 
primers, 1 mM MgCl2, and 0.2 mM dNTPs. The amplification of 
exon 3 was performed using the GC-RICH system (Roche Molec-
ular Biochemicals, Indianapolis, IN, USA) for its high GC con-
tent. The amplification for both exons was performed with an 
initial denaturation at 95°C for 8 min, followed by 35 cycles of 
denaturation at 95°C for 1 min, annealing at 62°C for 1 min, and 
extension at 72°C for 45 sec. Final extension was at 72°C for 10 
min. The PCR products were column-purified and sequenced 
on an Applied Biosystems 3130 genetic analyzers (Applied Bio-
systems).
Results of mutation
A polyalanine repeat expansion mutation was identified in the 
baby with CCHS. He carried a normal allele, as well as the ex-
panded alleles (Fig. 4). The expanded alleles contained inser-
tions of 18 bp DNAs for coding 6 alanines. An extra band with a 
Fig. 1. Electroencephalography at 13 days after birth was within normal limits. There 
were rare positive sharp waves over the right temporal region at T4, and no electro- 
graphic seizures. 
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Fig. 2. Changes of respiratory rate, PaCO2, and SpO2 during sleep and wakefulness 
while the patient was not supported by mechanical ventilation.  
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Fig. 3. Reverse sequence chromatogram from exon 3 of PHOX2B gene. Heterozygous 
frameshift mutation (PHOX2B NM_003924 : c.726_727insGCAGCGGCGGCGGCCGCG) 
was identified in the patient.
Table 1. Primer sequences* for the CCHS PHOX2B gene
Exon  Forward primers Reverse primers
1 GACCTCAGACAAGGCATCTCA AATTACCCCTCCCTGCAATC
2 CTGCCGTATGACCTGACCTT ACAGCCACACCAAATCCAGT
3 ACCCTAACCGGTGCTTTTCT ACAATAGCCTTGGGCCTACC
*Cited from Weese-Mayer et al. (9).Kwon K-A, et al.  •  A Case of Congenital Central Hypoventilation Syndrome with PHOX2B Gene Mutation
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size >232 bp was observed in the patient, indicating expansion 
of the polyalanine track. His mother had normal alleles (Fig. 4).
DISCUSSION
CCHS was suspected in the present case based on following 
findings: 1) hypoventilation during sleep with no increase of re-
spiratory frequency following severe desaturation, 2) onset of 
symptoms during the first day of life and a history of recurrent 
hypercapnic respiratory failure, and 3) absence of primary neu-
romuscular, lung or cardiac disease, or an identifiable brainstem 
lesion.
  CCHS occurs in association with Hirschsprung disease (Had-
dad syndrome) by 15-20% frequency, tumors of neural crest or-
igin (neuroblastoma, ganglioneuroblastoma, glanglioneuroma) 
by 3%, and growth hormone deficiency by <1% (13). Korean 
patients with CCHS combined with Hirschprung disease have 
been reported based on clinical symptoms without genetic anal-
ysis (3-7). The occurrence of CCHS and Hirschsprung disease 
suggests a common molecular pathogenesis involving defects 
of one or more genes that control the development of neural 
crest-derived cell lineages. This patient did not have any other 
abnormalities but will be monitored for a malignancy of the ANS 
in the future.
  The clinical outcome of CCHS is variable. Infants with CCHS 
may present with hypoventilation of variable severity, ranging 
from complete apnea during sleep, severe hypoventilation dur-
ing wakefulness, to mild hypoventilation during sleep (9, 14). 
The patient reported here, required a tracheostomy and used a 
home mechanical ventilator in the pressure-support mode. The 
patient became ambulatory while awake and intermittently re-
quired ventilator support during sleep only.
  The role of genes in the pathogenesis of CCHS has been wide-
ly investigated. Several studies have shown that a heterozygous 
mutation in PHOX2B is sufficient to cause CCHS, and this has 
confirmed its autosomal dominant inheritance pattern with in-
complete penetrance (9, 10, 15-19). This gene is known to code 
for a highly conserved transcription factor and plays a key role 
in the development of ANS reflex circuits in mice, hence the  
association with CCHS. Mapping of the PHOX2B mutation in 
chromosome 4p12 has been detected in approximately 97% of 
patients with CCHS, and the majority of expanded alleles con-
tained 25-27 polyalanine repeats (9). This patient showed the 
same PHOX2B mutation with expanded alleles containing 20 
polyalanine repeats. Weese-Mayer et al. (9) suggested that the 
length of the PHOX2B polyalanine repeat mutation is associat-
ed with number of ANS symptoms and that there is also a sig-
nificant association between the number of repeats in the muta-
tions and the ventilation support required. The current patient 
had a relatively small number of polyalanine repeats compared 
to previous cases and required intermittent ventilator support 
during sleep, which was for less than 12 hr a day.
  Clinically, evaluation of the PHOX2B expansion could be used 
as a predictive test for CCHS, therefore it might be particularly 
useful for parents of a child with CCHS and grown children with 
CCHS. In addition, prenatal testing can then be used to predict 
the severity of affected individuals in subsequent pregnancies. 
The identification of mutations in PHOX2B is important for the 
differential diagnosis in children with confusing symptoms such 
as asphyxia, prematurity, bronchopulmonary dysplasia, and 
neonatal seizures, and may lead to improved treatment options 
for children with CCHS (9). This is the first report of CCHS con-
firmed by a PHOX2B mutation in Korea.
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